India · Delayed Price · Currency is INR TTK Healthcare Statistics
Total Valuation
TTK Healthcare has a market cap or net worth of INR 12.90 billion. The enterprise value is 2.66 billion.
| Market Cap | 12.90B |
| Enterprise Value | 2.66B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
TTK Healthcare has 14.13 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 14.13M |
| Shares Outstanding | 14.13M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 8.31% |
| Owned by Institutions (%) | 3.60% |
| Float | 3.26M |
Valuation Ratios
The trailing PE ratio is 4.66.
| PE Ratio | 4.66 |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | 34.94 |
| P/OCF Ratio | 24.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.26, with an EV/FCF ratio of 7.20.
| EV / Earnings | 0.96 |
| EV / Sales | 0.29 |
| EV / EBITDA | 7.26 |
| EV / EBIT | 9.50 |
| EV / FCF | 7.20 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.91 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 0.77 |
| Interest Coverage | 21.95 |
Financial Efficiency
Return on equity (ROE) is 22.75% and return on invested capital (ROIC) is 8.22%.
| Return on Equity (ROE) | 22.75% |
| Return on Assets (ROA) | 1.19% |
| Return on Invested Capital (ROIC) | 8.22% |
| Return on Capital Employed (ROCE) | 2.07% |
| Weighted Average Cost of Capital (WACC) | 6.37% |
| Revenue Per Employee | 6.63M |
| Profits Per Employee | 2.00M |
| Employee Count | 1,384 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 4.21 |
Taxes
In the past 12 months, TTK Healthcare has paid 638.61 million in taxes.
| Income Tax | 638.61M |
| Effective Tax Rate | 18.76% |
Stock Price Statistics
The stock price has decreased by -21.71% in the last 52 weeks. The beta is 0.40, so TTK Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -21.71% |
| 50-Day Moving Average | 1,038.34 |
| 200-Day Moving Average | 962.04 |
| Relative Strength Index (RSI) | 36.97 |
| Average Volume (20 Days) | 1,015 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TTK Healthcare had revenue of INR 9.18 billion and earned 2.77 billion in profits. Earnings per share was 195.70.
| Revenue | 9.18B |
| Gross Profit | 4.65B |
| Operating Income | 279.89M |
| Pretax Income | 3.40B |
| Net Income | 2.77B |
| EBITDA | 359.23M |
| EBIT | 279.89M |
| Earnings Per Share (EPS) | 195.70 |
Balance Sheet
The company has 10.52 billion in cash and 283.05 million in debt, with a net cash position of 10.24 billion or 724.72 per share.
| Cash & Cash Equivalents | 10.52B |
| Total Debt | 283.05M |
| Net Cash | 10.24B |
| Net Cash Per Share | 724.72 |
| Equity (Book Value) | 13.47B |
| Book Value Per Share | 952.96 |
| Working Capital | 11.62B |
Cash Flow
In the last 12 months, operating cash flow was 516.23 million and capital expenditures -147.04 million, giving a free cash flow of 369.20 million.
| Operating Cash Flow | 516.23M |
| Capital Expenditures | -147.04M |
| Depreciation & Amortization | 79.33M |
| Net Borrowing | 8.14M |
| Free Cash Flow | 369.20M |
| FCF Per Share | 26.13 |
Margins
Gross margin is 50.65%, with operating and profit margins of 3.05% and 30.12%.
| Gross Margin | 50.65% |
| Operating Margin | 3.05% |
| Pretax Margin | 37.07% |
| Profit Margin | 30.12% |
| EBITDA Margin | 3.91% |
| EBIT Margin | 3.05% |
| FCF Margin | 4.03% |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 1.10%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 1.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.11% |
| FCF Payout Ratio | 38.27% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.09% |
| Earnings Yield | 21.44% |
| FCF Yield | 2.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |